← All trials
NCT06244771
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 12, 2024
- Primary completion
- Oct 31, 2027
- Completion date
- Apr 30, 2028
- First posted
- Feb 6, 2024
- Last posted
- Oct 28, 2024
- Enrollment
- 403
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Frontier Medicines CorporationLead sponsor
- Frontier Medicines CorporationOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.